地中海饮食与老年阿尔茨海默病生物标志物及脑萎缩的关系
该横断面研究纳入德国DZNE纵向认知障碍与痴呆研究的512名参与者(平均年龄69.5±5.9岁),评估地中海饮食(MeDi)依从性与认知功能、脑体积及脑脊液AD生物标志物的关联。结果显示,较高MeDi依从性与较大的内侧颞叶灰质体积、更好的记忆、较低的淀粉样蛋白和pTau181病理相关,且内侧颞叶体积中介了MeDi与记忆的关联(40%间接中介)。
要点
- 较高MeDi依从性与更好的记忆表现和较大的内侧颞叶灰质体积相关。
- MeDi依从性越高,脑脊液Aβ42/40比值越高、pTau181越低,提示AD病理更轻。
- 内侧颞叶体积部分中介MeDi与记忆的关联,中介比例为40%。
核心结论
- 研究结果支持MeDi作为记忆下降和内侧颞叶萎缩的保护因素,且这种关联可能由淀粉样蛋白和tau病理减少解释。
研究设计与样本
- 横断面研究,样本来自德国DZNE纵向认知障碍与痴呆研究,n=512,平均年龄69.5±5.9岁。
- 样本包括169名认知正常者、53名有AD家族史者、209名主观认知下降者和81名轻度认知障碍者。
- MeDi依从性基于食物频率问卷定义,脑体积通过T1-MRI基于体素的形态学分析,认知通过广泛神经心理测验评估。
- 脑脊液AD生物标志物(Aβ42/40比值、pTau181)在n=226人中检测。
主要发现
- 较高MeDi依从性与较大的内侧颞叶灰质体积相关(p<0.05 FWE校正)。
- 较高MeDi依从性与更好的记忆表现相关(β±SE = 0.03 ± 0.02;p=0.038)。
- 较高MeDi依从性与较低的淀粉样蛋白病理相关(Aβ42/40比值,β±SE = 0.003 ± 0.001;p=0.008)。
- 较高MeDi依从性与较低的pTau181病理相关(β±SE = -1.96±0.68;p=0.004)。
- 内侧颞叶体积中介MeDi与记忆的关联(40%间接中介),且MeDi有利地调节Aβ42/40比值、pTau181与内侧颞叶萎缩的关联。
关键数值与推荐
- MeDi依从性基于食物频率问卷定义。
- 脑体积结局通过T1-MRI基于体素的形态学分析生成。
- 认知表现通过广泛神经心理测验评估。
- 脑脊液AD生物标志物包括Aβ42/40比值和pTau181,在n=226人中评估。
临床怎么用
- 在临床评估中,可将MeDi依从性作为认知下降和AD风险的潜在可干预因素进行询问。
- 对于AD高风险人群,鼓励地中海饮食可能有助于保护记忆和内侧颞叶结构。
局限性
- 研究为横断面设计,无法确定因果关系。
- 需要纵向和饮食干预研究进一步验证该假设及其治疗意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether following a Mediterranean-like diet (MeDi) relates to cognitive functions and in vivo biomarkers for Alzheimer disease (AD), we analyzed cross-sectional data from the German DZNE-Longitudinal Cognitive Impairment and Dementia Study. METHOD: The sample (n=512, mean age: 69.5±5.9 years) included 169 cognitively normal participants and subjects at higher AD risk (53 with relatives with AD, 209 with subjective cognitive decline, and 81 with mild cognitive impairment). We defined MeDi adherence based on the Food Frequency Questionnaire. Brain volume outcomes were generated via voxel-based morphometry on T1-MRI and cognitive performance with an extensive neuropsychological battery. AD-related biomarkers (Aβ42/40 ratio, pTau181) in cerebrospinal fluid were assessed in n=226 individuals. We analyzed the associations between MeDi and the outcomes with linear regression models controlling for several covariates. Additionally, we applied hypothesis-driven mediation and moderation analysis. RESULTS: Higher MeDi adherence related to larger mediotemporal gray matter volume (p<0.05 FWE corrected), better memory (β±SE = 0.03 ± 0.02; p=0.038), and less amyloid (Aβ42/40 ratio, β±SE = 0.003 ± 0.001; p=0.008) and pTau181 pathology (β±SE = -1.96±0.68; p=0.004). Mediotemporal volume mediated the association between MeDi and memory (40% indirect mediation). Finally, MeDi favorably moderated the associations between Aβ42/40 ratio, pTau181 and mediotemporal atrophy. Results were consistent correcting for ApoE-ε4 status. CONCLUSION: Our findings corroborate the view of MeDi as a protective factor against memory decline and mediotemporal atrophy. Importantly, they suggest that these associations might be explained by a decrease of amyloidosis and tau-pathology. Longitudinal and dietary intervention studies should further examine this conjecture and its treatment implications.
引用
- Ballarini T, Melo van Lent D, Brunner J, et al. Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age. Neurology. 2021. PMID: 33952652. doi:10.1212/WNL.0000000000012067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。